NC6 0.00% 1.9¢ nanollose limited

Ann: Quarterly Update and Appendix 4C, page-5

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 65 Posts.
    lightbulb Created with Sketch. 2
    Could somebody please enlighten us of what the company's primary objective is? The CEO provided guidance in an interview that the ball will start rolling in around 3-4 months' time. What exactly will the company have in that time? Is the primary objective the development of a durable fibre sourced from microbial cellulose for textiles applications or something else?

    I feel anybody comparing this stock to the likes of NOX or RAC are a little off base. These biotech companies have clear-cut milestones concerning funding, clinical trials and regulatory approval. With patents pending and competition with other foreign companies being a grey area, understanding NAN's prospects appears far more complex and uncertain. Does anybody have anything meaningful to add?
    Last edited by Slazer: 31/01/18
 
watchlist Created with Sketch. Add NC6 (ASX) to my watchlist
(20min delay)
Last
1.9¢
Change
0.000(0.00%)
Mkt cap ! $3.268M
Open High Low Value Volume
1.9¢ 1.9¢ 1.9¢ $943 49.65K

Buyers (Bids)

No. Vol. Price($)
1 96470 1.7¢
 

Sellers (Offers)

Price($) Vol. No.
1.9¢ 69712 1
View Market Depth
Last trade - 14.46pm 08/10/2024 (20 minute delay) ?
NC6 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.